Portugal – Healthcare, Regulatory and Reimbursement Landscape

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$1995
Buy Report View Sample

Published: October 29, 2021 Report Code: GDHC0038CHR-ST

Select Item

GlobalData, the industry analysis specialist, has released its latest report, “Portugal – Healthcare, Regulatory and Reimbursement Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Portugal. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Portuguese pharmaceutical market was valued at €2.61B in 2012, which increased to €2.81 in 2020 at a Compound Annual Growth Rate (CAGR) of 0.90%. It is forecast to reach €2.91B in 2025 at 1.0% CAGR. In terms of US dollars, it was valued at $3.36B in 2012, which decreased at a negative CAGR of 0.57% to $3.21B in 2020. The market value is expected to decrease further to $3.12B by 2025. This difference is due to currency exchange fluctuations. The medical devices market in Portugal was worth $1.10B in 2015, which increased at a CAGR of 4.68% to $1.38B in 2020. It is expected to grow at a CAGR of 3.13% from 2020 to reach $1.61B in 2025. Portugal is a hybrid of public and private sectors, offering excellent healthcare services with universal coverage, innovative healthcare infrastructure, and new emerging technologies.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Portugal, and includes:

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

Profiles and SWOT analyses of the major players in the pharmaceutical market: Bayer, Merck, AstraZeneca, Sanofi, and Teva Pharmaceuticals

Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, Stryker, Olympus, and Smith & Nephew

An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices

Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure

An overview of the opportunities for and challenges to growth in the Portuguese healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to:

Develop business strategies by understanding the trends shaping and driving Portuguese’s healthcare market

Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact Portuguese’s healthcare market in the future

Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance

Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

Table of Contents

1 Table of Contents

2 Executive Summary

2.1 Executive Summary

2.2 Key Highlights – Facts about the Portugal Healthcare Market

2.3 Key Highlights: Healthcare Startups in Portugal

2.4 Key Events: Portugal Healthcare Industry, 2015-2021

2.5 Key Events: Portugal Pharmaceutical Market

2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2020-2021

2.7 Key Events: Mergers and Acquisitions

2.8 Country Profile, Portugal, 2020

3 Overview of Pharmaceutical Market

3.1 Pharmaceutical Market – Overview

3.2 Pharmaceutical Market – Exports

3.3 Pharmaceutical Market – Imports

3.4 Pharmaceutical Market – Supply Channels, Portugal

3.5 Pharmaceutical Market – Market Segments

3.6 Major Therapeutic Areas, Portugal

3.7 COVID-19 Epidemiology, Portugal

3.8 COVID-19 Impact and Developments in the Healthcare Market, Portugal

3.9 COVID-19 Clinical Trials Landscape, Portugal

3.10 Pharmaceutical Market – Major Players

4 Overview of Medical Devices Market

4.1 Medical Device Market – Overview

4.2 Medical Devices Market – Major Players

5 Pharmaceutical and Medical Devices Market – Drivers and Barriers

5.1 Drivers

5.2 Barriers

6 Deal Analysis

6.1 Deal Analysis: Pharmaceutical Market, Portugal, 2019-2021

6.2 Deal Analysis: Medical Device Market, Portugal, 2019-2021

7 HealthTech Landscape

7.1 HealthTech Landscape, Portugal

7.2 Adoption of Technology in Healthcare, Portugal

7.3 HealthTech Deals Landscape, Portugal

7.4 Key HealthTech Deals, Portugal

7.5 Regulatory Scenario Covering Use of Technology in Healthcare, Portugal

7.6 HealthTech Landscape: Benefits and Risks, Portugal

8 Market Access

8.1 Overview of Healthcare System, Portugal

8.2 Reimbursement Process, Portugal

8.3 Overview of Insurance Providers, Portugal

8.4 Healthcare Spending and Consumer Price Index, Portugal

8.5 Pricing Policies, Portugal

8.6 Regulatory Landscape, Portugal

8.6.1 Overview of Regulatory Agencies

8.6.2 Marketing Authorization for Pharmaceutical Products, EU

8.6.3 Market Authorization for Pharmaceutical Products (National Procedure), Portugal

8.6.4 Market Authorization for Pharmaceutical Products (Centralized Procedure), Portugal

8.6.5 Marketing Authorization for Pharmaceutical Products (Decentralized Procedure), Portugal

8.6.6 Marketing Authorization for Pharmaceutical Products (Mutual Recognition Procedure), Portugal

8.6.7 Marketing Authorization for Medical Devices, Portugal

8.6.8 Intellectual Property Rights, Patent, Portugal

8.6.9 Intellectual Property Rights, European Patent, Portugal

8.6.10 Intellectual Property Rights, Unitary Patent, Portugal

8.6.11 Intellectual Property Rights, Trademark, Portugal

8.6.12 Clinical Trial Regulation, Portugal

8.6.13 Pharmaceutical Clinical Trials Landscape, Portugal

8.6.14 Medical Devices Clinical Trials Landscape, Portugal

8.6.15 Pharmaceutical Export and Import, Portugal

8.6.16 Pharmacy Regulations, Portugal

8.6.17 Pharmaceutical Advertisement Regulations, Portugal

8.6.18 Labeling and Packaging Regulations, Portugal

9 Country Healthcare Landscape

9.1 Healthcare Policy Highlights, Portugal

9.2 Healthcare Facilities, Portugal

9.3 Healthcare Parameters, Portugal

9.4 Life Expectancy and Immunization Rate, Portugal

9.5 Environmental Health, Portugal

9.6 Healthcare Personnel, Portugal

9.7 Disease Burden, Portugal

9.8 Healthcare Expenditure, Portugal

10 Trade Associations, Portugal

11 Trade Fairs, Portugal

12 Opportunities and Challenges

13 Appendix

13.1 Research Methodology

13.1.1 Coverage

13.1.2 Secondary Research

13.1.3 Forecasts

13.2 Bibliography

13.3 About GlobalData

13.4 Contact Us

13.5 Disclaimer

Table

Table 1: COVID-19 Indicators (Number of Cases), Portugal and Global, 2020-2021

Table 2: Warning Levels and the Portuguese Response to the COVID-19 Crisis, 2020

Table 3: Authorized COVID-19 Vaccines, Portugal, 2020-2021

Table 4: Medical Devices Market, Portugal, Major Segments ($M), 2020

Table 5: Hospital Supplies Market, Portugal, Revenue ($M) and Market Share (%) of Major Companies, 2020

Table 6: Cardiovascular Devices Market, Portugal, Revenue ($M) and Market Share (%) of Major Companies, 2020

Table 7: General Surgery Market, Portugal, Revenue ($M) and Market Share (%) of Major Companies, 2020

Table 8: Diabetes Care Devices Market, Portugal, Revenue ($M) and Market Share (%) of Major Companies, 2020

Table 9: Orthopedic Devices, Portugal, Revenue ($M) and Market Share (%) of Major Companies, 2020

Table 10: Patent Fees, Portugal, 2020

Table 11: Trademark Fees, Portugal, 2021

Table 12: Clinical Trial Process Fees, Portugal, 2020

Table 13: Trade Fairs, Portugal

Figures

Figure 1: Pharmaceutical Market, Portugal, Revenue ($B and €B), 2012-2020

Figure 2: Medical Devices Market, Portugal, Revenue ($B), 2015-2020

Figure 3: Healthcare Start-Ups in Portugal, 2020

Figure 4: Country Profile, Portugal, 2020

Figure 5: Pharmaceutical Market, Portugal, Revenue ($B), 2012-2020

Figure 6: Pharmaceutical Market, Portugal, Revenue Forecast ($B), 2021-2025

Figure 7: Pharmaceutical Exports ($B), Portugal, 2012-2020

Figure 8: Top Export Partners, Portugal, 2020

Figure 9: Pharmaceutical Imports ($B), Portugal, 2012-2020

Figure 10: Top Import Partners, Portugal, 2020

Figure 11: Pharmaceutical Market, Supply Channel, Portugal, 2021

Figure 12: Generic Drugs Usage (Share by Volume), Portugal, 2012-2020

Figure 13: Generic Drugs Usage (Share by Value), Portugal, 2012-2020

Figure 14: OTC Medicines Market, Major Categories ($M), Portugal, 2020

Figure 15: OTC Medicines Market, Revenue ($M), Portugal, 2012-2020

Figure 16: OTC Medicines Market, Major Distribution Channels ($M), Portugal, 2020

Figure 17: Total Drug Expenditure by Therapeutic Class ($M), Portugal, 2020

Figure 18: Major Therapeutic Areas by Pharmaceutical Sales ($M), Portugal, 2018-2020

Figure 19: COVID-19, Number of Confirmed Cases, Portugal, 2020-2021

Figure 20: COVID-19, Number of Deaths, Portugal, 2020-2021

Figure 21: COVID-19-Related Travel Restrictions, Portugal, 2020-2021

Figure 22: COVID-19 Fiscal Stimulus Timeline, Portugal, 2020-2021

Figure 23: Vaccine Doses Administered per 1,000 People, Portugal, 2021

Figure 24: COVID-19 Clinical Trials Count by Trial Status, Portugal, 2020-2021

Figure 25: COVID-19 Clinical Trials Count by Phase, Portugal, 2020-2021

Figure 26: COVID-19 Clinical Trials Sponsors by Trial Count, Portugal, 2020-2021

Figure 27: Top COVID-19 Marketed Products by Category (Number of Available Marketed Products), Portugal

Figure 28: Top COVID-19 IVD Products by Equipment Type (Number of Available Marketed Products), Portugal

Figure 29: Top COVID-19 Marketed Products by Product Class (Number of Available Marketed Products), Portugal

Figure 30: Top Five Company/University Name by Count, Portugal

Figure 31: Medical Devices Market, Portugal, Revenue ($B), 2015-2020

Figure 32: Medical Devices Market, Portugal, Revenue Forecast ($B), 2021-2025

Figure 33: Medical Devices Market, Portugal, Major Segments (%), 2020

Figure 34: Hospital Supplies Market, Portugal, Revenue ($M), 2017-2025

Figure 35: Hospital Supplies Market, Portugal, Market Share of Major Players (%), 2020

Figure 36: Cardiovascular Devices Market, Portugal, Revenue ($M), 2017-2025

Figure 37: Cardiovascular Devices Market, Portugal, Market Share of Major Players (%), 2020

Figure 38: General Surgery Market, Portugal, Revenue ($M), 2017-2025

Figure 39: General Surgery Market, Portugal, Market Share of Major Players (%), 2020

Figure 40: Diabetes Care Devices Market, Portugal, Revenue ($M), 2017-2025

Figure 41: Diabetes Care Devices Market, Portugal, Market Share of Major Players (%), 2020

Figure 42: Orthopedic Devices Market, Portugal, Revenue ($M), 2017-2025

Figure 43: Orthopedic Devices Market, Portugal, Market Share of Major Players (%), 2020

Figure 44: Diagnostics Market, Portugal, Revenue ($M), 2015-2020

Figure 45: Diagnostics Market, Portugal, Revenue Forecast ($M), 2021-2025

Figure 46: Deal Value and Deal Count, Pharmaceutical Market, Portugal, 2019-2021

Figure 47: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Portugal, 2019-2021

Figure 48: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Portugal, 2019-2021

Figure 49: Top Therapy Areas by Deal Value, Pharmaceutical Market, Portugal, 2019-2021

Figure 50: Top Therapy Areas by Deal Count, Pharmaceutical Market, Portugal, 2019-2021

Figure 51: M&A Deals by Quarter, Pharmaceutical Market, Portugal, 2019-2021 (by value and by number)

Figure 52: Deal Value and Deal Count, Medical Devices Market, Portugal, 2019-2021

Figure 53: Deal Value and Deal Count Sub-types, Medical Devices Market, Portugal, 2019-2021

Figure 54: Deal Value and Deal Count, Quarterly, Medical Devices Market, Portugal, 2019-2021

Figure 55: Top Equipment Sectors by Deal Value, Medical Devices Market, Portugal, 2019-2021

Figure 56: Top Equipment Sectors by Deal Count, Medical Devices Market, Portugal, 2019-2021

Figure 57: M&A Deals by Equipment Sector, Medical Devices Market, Portugal, 2019-2021 (by value and by number)

Figure 58: VC Deals by Quarter, Medical Devices Market, Portugal, 2019-2021 (by value and by number)

Figure 59: Methodology Adopted for the Elaboration of PENTS, Portugal

Figure 60: TeleHealth Timeline in Portugal

Figure 61: Objectives of AI Portugal 2030

Figure 62: Interacting Processes of AI Portugal 2030

Figure 63: Areas of specialization in Portugal

Figure 64: Adoption of Technology in Healthcare, Portugal

Figure 65: Deal Value ($M), HealthTech, Portugal, 2019-2021

Figure 66: Deal Count (Number of Deals), HealthTech, Portugal, 2019-2021

Figure 67: GDPR Compliance Checklist, EU, 2021

Figure 68: Overview of Healthcare System, Portugal, 2020

Figure 69: Key Areas Covered by SiNATS

Figure 70: Overview of Financial Flow, Portugal, 2020

Figure 71: Drug Reimbursement Process, Portugal

Figure 72: OOP Expenditure (% of HealthSpending), Portugal, 2012-2019

Figure 73: Annual Average Rate of Change (%), Consumer Price Index, Healthcare Products, Portugal, 2012-2020

Figure 74: INFARMED Organizational Structure, Portugal, 2020

Figure 75: Marketing Authorization for Pharmaceutical Products, EU, 2020

Figure 76: National Procedure, Portugal, 2021

Figure 77: Centralized Procedure, EU, 2021

Figure 78: Decentralized Procedure, EU, 2021

Figure 79: Mutual Recognition Procedure,EU,2021

Figure 80: Conformity Assessment of Class I Medical Devices, EU, 2020

Figure 81: Conformity Assessment of Class IIa Medical Devices, EU, 2020

Figure 82: Conformity Assessment of Class IIb Medical Devices, EU, 2020

Figure 83: Conformity Assessment of Class III Medical Devices, EU, 2020

Figure 84: Patent Approval Process, Portugal, 2021

Figure 85: European Patent Approval Process, EU, 2020

Figure 86: Unitary Patent Approval Process, EU, 2020

Figure 87: Trademark Approval Process, Portugal, 2021

Figure 88: Clinical Trial Regulation Process, Portugal, 2020

Figure 89: Pharmaceutical Clinical Trials Count by status Portugal, 2019-2021

Figure 90: Pharmaceutical Clinical Trials Count by Trial Phase, Portugal, 2019-2021

Figure 91: Pharmaceutical Clinical Trials Count by Therapy Area, Portugal, 2019-2021

Figure 92: Top Five Pharmaceutical Clinical Trials Sponsors by Count, Portugal, 2019-2021

Figure 93: Medical Devices Clinical Trials Count by Trial Status, Portugal, 2019-2021

Figure 94: Medical Devices Clinical Trials Count by Indication, Portugal, 2019-2021

Figure 95: Medical Devices Clinical Trials Count by Device Category, Portugal, 2019-2021

Figure 96: Top Five Medical Devices Clinical Trials Sponsors by Count, Portugal, 2019-2021

Figure 97: Number of Hospitals, Portugal, 2012-2019

Figure 98: Number of Diagnostic Equipment, Portugal, 2012-2019

Figure 99: Hospital Beds (per 1,000 Population), Portugal, 2012-2019

Figure 100: Acute Care Hospital Beds (per 1,000 Population), Portugal, 2012-2019

Figure 101: Psychiatric Care Hospital Beds (per 1,000 Population), Portugal, 2012-2019

Figure 102: Immunization Rate (%), Portugal, 2013-2019

Figure 103: Life Expectancy at Birth (Years), Portugal, 2012-2019

Figure 104: CO2 Emissions (Million Tons), Portugal, 2012-2018

Figure 105: PM2.5 (µg per m3), Portugal, 2011-2017

Figure 106: Physicians (per 1,000 Population), Portugal, 2012-2019

Figure 107: Dentists (per 1,000 Population), Portugal, 2012-2019

Figure 108: Pharmacists (per 1,000 Population), Portugal, 2012-2019

Figure 109: Nurses (per 1,000 Population), Portugal, 2012-2019

Figure 110: Major Causes of Mortality (per 100,000 Population), Portugal, 2019

Figure 111: Major Causes of Male Mortality (per 100,000 Population), Portugal, 2019

Figure 112: Major Causes of Female Mortality (per 100,000 Population), Portugal, 2019

Figure 113: Disability-Adjusted Life Years by Major Disease (per 100,000 Population), Portugal, 2019

Figure 114: Current Healthcare Expenditure as Percentage of GDP (%), Portugal, 2012-2019

Figure 115: Health Expenditure Share (% of Total Health Spending), Portugal, 2012-2019

Figure 116: Pharmaceutical Spending (% Total Health Spending), Portugal, 2012-2019

Figure 117: Expenditure Components by Function (% of Total Health Expenditure), Portugal, 2019

Frequently asked questions

Portugal – Healthcare, Regulatory and Reimbursement Landscape standard reports
Currency USD
$1,995

Can be used by individual purchaser only

Most Popular
$3,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$5,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Portugal – Healthcare, Regulatory and Reimbursement Landscape was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Pharmaceuticals reports
Pharmaceuticals
New
Antibody-Drug Conjugates (ADC) Overview, Industry Trends, Marketed and Pipeline Products,…
$6,995 | March 2024
Pharmaceuticals
New
Cell and Gene Therapies in Ophthalmology - Disease Overview, Treatment…
$6,995 | March 2024
Pharmaceuticals
New
Generic Drugs - Physician Perspective - Thematic Intelligence
$1,495 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Portugal – Healthcare, Regulatory and Reimbursement Landscape in real time.

  • Access a live Portugal – Healthcare, Regulatory and Reimbursement Landscape dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more